4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-027344
President and CEO sold 28,502 shares at an average $6.23 ($177,509)
From the SEC's structured data for this filing
Trades in this filing
Paulson Richard A. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-04 | Sale : show line 1 in the form | −633 | $6.26 | $3,963 | 661,317 | D |
| 2022-05-04 | Sale : show line 2 in the form | −27,869 | $6.23 | $173,546 | 633,448 | D |
| Open-market sales · 28,502 sh · avg $6.23 · $177,509 | ||||||
Loading xslF345X03/doc4.xml…